GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Taro Pharmaceutical Industries Ltd (NYSE:TARO) » Definitions » Market Cap

Taro Pharmaceutical Industries (Taro Pharmaceutical Industries) Market Cap : $1,593.6 Mil (As of Apr. 28, 2024)


View and export this data going back to 1987. Start your Free Trial

What is Taro Pharmaceutical Industries Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Taro Pharmaceutical Industries's share price for the quarter that ended in Dec. 2023 was $41.78. Taro Pharmaceutical Industries's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 37.6 Mil. Therefore, Taro Pharmaceutical Industries's market cap for the quarter that ended in Dec. 2023 was $1,570.3 Mil.

Taro Pharmaceutical Industries's quarterly market cap declined from Jun. 2023 ($1,425.6 Mil) to Sep. 2023 ($1,417.3 Mil) but then increased from Sep. 2023 ($1,417.3 Mil) to Dec. 2023 ($1,570.3 Mil).

Taro Pharmaceutical Industries's annual market cap declined from Mar. 2021 ($2,797.0 Mil) to Mar. 2022 ($1,625.9 Mil) and declined from Mar. 2022 ($1,625.9 Mil) to Mar. 2023 ($914.1 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Taro Pharmaceutical Industries's Enterprise Value for Today is $745.2 Mil.


Taro Pharmaceutical Industries Market Cap Historical Data

The historical data trend for Taro Pharmaceutical Industries's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taro Pharmaceutical Industries Market Cap Chart

Taro Pharmaceutical Industries Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,165.66 2,341.40 2,797.04 1,625.91 914.06

Taro Pharmaceutical Industries Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,091.46 914.06 1,425.58 1,417.32 1,570.28

Competitive Comparison of Taro Pharmaceutical Industries's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Taro Pharmaceutical Industries's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Taro Pharmaceutical Industries's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Taro Pharmaceutical Industries's Market Cap distribution charts can be found below:

* The bar in red indicates where Taro Pharmaceutical Industries's Market Cap falls into.



Taro Pharmaceutical Industries Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Taro Pharmaceutical Industries's Market Cap for the fiscal year that ended in Mar. 2023 is calculated as

Market Cap (A: Mar. 2023 )=Share Price (A: Mar. 2023 )*Shares Outstanding (EOP) (A: Mar. 2023 )
=$24.32*37.5846
=$914.1

Taro Pharmaceutical Industries's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )=Share Price (Q: Dec. 2023 )*Shares Outstanding (EOP) (Q: Dec. 2023 )
=$41.78*37.5846
=$1,570.3

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Taro Pharmaceutical Industries  (NYSE:TARO) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Taro Pharmaceutical Industries Market Cap Related Terms

Thank you for viewing the detailed overview of Taro Pharmaceutical Industries's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Taro Pharmaceutical Industries (Taro Pharmaceutical Industries) Business Description

Traded in Other Exchanges
Address
14 Hakitor Street, P.O. Box 10347, Haifa Bay, Haifa, ISR, 2624761
Taro Pharmaceutical Industries Ltd produces, researches, develops, and markets pharmaceutical products. Its primary focus includes semi-solid formulations, such as creams and ointments, and other dosage forms such as liquids, capsules, and tablets. The company is engaged in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Israel, and Other Countries.
Executives
Sun Pharma Global Inc 10 percent owner
Sun Pharmaceutical Industries Ltd 10 percent owner, other: Affiliated Party 17/B, MAHAL INDUSTRIAL ESTATE, MAHAKALI CAVES ROAD, ANDEHERI (EAST) K7 400 093
Alkaloida Chemical Co Exclusive Group Ltd. 10 percent owner KABAY JANOS UT 29., TISZAVASVARI K5 4440
Franklin Resources Inc 10 percent owner FRANKLIN RESOURCES INC, ONE FRANKLIN PARKWAY, SAN MATEO CA 94403

Taro Pharmaceutical Industries (Taro Pharmaceutical Industries) Headlines